title: Sudden infant death syndrome, child sexual abuse, and child development.
abstract: Since the introduction of the Back to Sleep Campaigns, there has been a dramatic reduction in sudden infant death syndrome in this country. Steven Blatt and Victoria Meguid review the literature surrounding sleep position. Investigators have continued efforts to find other modifiable risk factors of sudden infant death syndrome. A prospective study of more than 33,000 neonates found a link between a prolonged QT electrocardiogram interval and sudden infant death syndrome. Also discussed are investigations seeking to explain the relationship between smoking and sudden infant death syndrome. Ann Botash, Florence Jean-Louis and Mongkae Ploy Siripornsawan review the latest thinking on genital warts and their relation to specific viral etiologies and child sexual abuse. Other symptoms and signs of sexual abuse are the focus of a number of articles that can help the practitioner care for these unfortunate children. Catherine Church reviews medication options for children diagnosed with pervasive developmental disorders or autism spectrum disorders. Finally, in this article, risperidone, fluoxetine and naltrexone are reviewed.
authors: State University of New York, Health Science Center at Syracuse 13210, USA.
authors: S D
authors: SD
authors: Blatt
authors: V
authors: V
authors: Meguid
authors: C C
authors: CC
authors: Church
authors: A S
authors: AS
authors: Botash
authors: F
authors: F
authors: Jean-Louis
authors: M P
authors: MP
authors: Siripornsawan
authors: H L
authors: HL
authors: Weinberger
mesh_terms: D001321:Autistic Disorder / Q000188:drug therapy*; D002648:Child; D002650:Child Abuse, Sexual / Q000175:diagnosis; D002675:Child, Preschool; D003218:Condylomata Acuminata; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D027383:Papillomaviridae; D030361:Papillomavirus Infections; D018967:Risperidone / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013398:Sudden Infant Death / Q000453:epidemiology
chemical_list: D005473:Fluoxetine; D009271:Naltrexone; D009292:Narcotic Antagonists; D018967:Risperidone; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors